Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use (2009)

Peer-Reviewed Study · Pollack G, Pollack A, Delfiner J, Fernandez J · October 2009

Pollack G et al., 2009-10: Review reporting that 26 cases of toxic metabolic encephalopathy had been published after methylene blue for parathyroid surgery, attributing them to MAOI-mediated serotonin toxicity, and proposing guidelines for safe intraoperative use.

Twenty-six cases of a toxic metabolic encephalopathy, however, have been reported with its use.

Pollack G et al., 2009-10: Review reporting that 26 cases of toxic metabolic encephalopathy had been published after methylene blue for parathyroid surgery, attributing them to MAOI-mediated serotonin toxicity, and proposing guidelines for safe intraoperative use. C2. Supports the element that the cases behind the warning were parathyroid-surgery intravenous cases; contradicts the element that there were only "a handful". Dose/route: 7.5 mg/kg in 100 mL D5W infused before surgery (standard protocol at the time); the paper also notes the UK National Poisons Information Service recommends a dose not exceeding 4 mg/kg. Funder/conflicts: not stated in abstract. The abstract reports the case count; the dose detail is from the publisher's free full text preview on the same PubMed record page, not the abstract line quoted. Study type: review.